Alain Thibault
Corporate Officer/Principal chez ANNEXIN PHARMACEUTICALS AB
Profil
Alain Thibault is currently the Head-Oncology at Annexin Pharmaceuticals AB since 2023.
He previously worked as the Chairman-Clinical Pharmacology at National Cancer Institute, Senior Medical Director at Johnson & Johnson, Director at Hoffmann-La Roche, Inc., Senior Director-Clinical Development at Gemin X Pharmaceuticals US, Inc., Vice President-Clinical Sciences & Oncology at Regeneron Pharmaceuticals, Inc. from 2009 to 2011, Assistant Professor at the University of Virginia, and Chief Medical Officer at argenx SE.
Dr. Thibault obtained a doctorate degree from McGill University.
Postes actifs de Alain Thibault
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Corporate Officer/Principal | 18/01/2023 |
Anciens postes connus de Alain Thibault
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur/Membre du Conseil | - |
| ARGENX SE | Directeur Technique/Scientifique/R&D | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Directeur Financier/CFO | - |
| University of Virginia | Corporate Officer/Principal | - |
Formation de Alain Thibault
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| ARGENX SE | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
